These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 33084192)

  • 1. Assessing physical symptoms, daily functioning, and well-being in children with achondroplasia.
    Pfeiffer KM; Brod M; Smith A; Gianettoni J; Viuff D; Ota S; Charlton RW
    Am J Med Genet A; 2021 Jan; 185(1):33-45. PubMed ID: 33084192
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Assessing the impacts of having a child with achondroplasia on parent well-being.
    Pfeiffer KM; Brod M; Smith A; Gianettoni J; Viuff D; Ota S; Charlton RW
    Qual Life Res; 2021 Jan; 30(1):203-215. PubMed ID: 32803627
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Functioning and well-being in older children and adolescents with achondroplasia: A qualitative study.
    Pfeiffer KM; Brod M; Smith A; Viuff D; Ota S; Charlton RW
    Am J Med Genet A; 2022 Feb; 188(2):454-462. PubMed ID: 34643322
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A qualitative study of the impacts of having an infant or young child with achondroplasia on parent well-being.
    Pfeiffer KM; Brod M; Smith A; Viuff D; Ota S; Charlton RW
    Orphanet J Rare Dis; 2021 Aug; 16(1):351. PubMed ID: 34362417
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An ICF-CY-based approach to assessing self- and observer-reported functioning in young persons with achondroplasia - development of the pilot version of the Achondroplasia Personal Life Experience Scale (APLES).
    Sommer R; Blömeke J; Dabs M; Witt S; Bullinger M; Quitmann J
    Disabil Rehabil; 2017 Dec; 39(24):2499-2503. PubMed ID: 27636099
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Key measurement concepts and appropriate clinical outcome assessments in pediatric achondroplasia clinical trials.
    Aldhouse NVJ; Kitchen H; Johnson C; Marshall C; Pegram H; Pease S; Collins S; Baker CL; Beaverson K; Crews C; Massey J; Wyrwich KW
    Orphanet J Rare Dis; 2022 May; 17(1):182. PubMed ID: 35525989
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cross-cultural selection and validation of instruments to assess patient-reported outcomes in children and adolescents with achondroplasia.
    Bloemeke J; Sommer R; Witt S; Bullinger M; Nordon C; Badia FJ; González FL; Leiva-Gea A; Delgado Rufino FB; Mayoral-Cleries F; Romero-Sanchiz P; Clamagirand Saiz V; Nogueira-Arjona R; Mohnike K; Quitmann J
    Qual Life Res; 2019 Sep; 28(9):2553-2563. PubMed ID: 31093848
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Piloting and psychometric properties of a patient-reported outcome instrument for young people with achondroplasia based on the International Classification of Functioning Disability and Health: the Achondroplasia Personal Life Experience Scale (APLES).
    Bloemeke J; Sommer R; Witt S; Dabs M; Badia FJ; Bullinger M; Quitmann J
    Disabil Rehabil; 2019 Jul; 41(15):1815-1825. PubMed ID: 29516753
    [No Abstract]   [Full Text] [Related]  

  • 9. Living with hypoparathyroidism: development of the Hypoparathyroidism Patient Experience Scale-Impact (HPES-Impact).
    Brod M; Waldman LT; Smith A; Karpf D
    Qual Life Res; 2021 Jan; 30(1):277-291. PubMed ID: 32833143
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development of Focal Segmental Glomerulosclerosis Patient-Reported Outcome Measures: Symptom Diary and Symptom Impact Questionnaire.
    Mathias SD; Vallow S; Gipson DS; Thorneloe KS; Sprecher D
    Am J Kidney Dis; 2017 Oct; 70(4):532-540. PubMed ID: 28663063
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development of the Pulmonary Arterial Hypertension-Symptoms and Impact (PAH-SYMPACT®) questionnaire: a new patient-reported outcome instrument for PAH.
    McCollister D; Shaffer S; Badesch DB; Filusch A; Hunsche E; Schüler R; Wiklund I; Peacock A;
    Respir Res; 2016 Jun; 17(1):72. PubMed ID: 27301413
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Quality of life of children with achondroplasia and their parents - a German cross-sectional study.
    Witt S; Kolb B; Bloemeke J; Mohnike K; Bullinger M; Quitmann J
    Orphanet J Rare Dis; 2019 Aug; 14(1):194. PubMed ID: 31399110
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Assessing the Patient Experience of Hypoparathyroidism Symptoms: Development of the Hypoparathyroidism Patient Experience Scale-Symptom (HPES-Symptom).
    Brod M; Waldman LT; Smith A; Karpf D
    Patient; 2020 Apr; 13(2):151-162. PubMed ID: 31552607
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Vulvodynia Experience Questionnaire: Qualitative Development of a New Patient-Reported Outcome Measure for Vulvodynia.
    Goldstein AT; Diez PMQ; Kapanadze S; Cala ML; Evans CJ; Whyte JL; Christoph A
    J Sex Med; 2020 Oct; 17(10):2055-2066. PubMed ID: 32900670
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Health-related quality of life in children and adolescents who have a diagnosis of attention-deficit/hyperactivity disorder.
    Klassen AF; Miller A; Fine S
    Pediatrics; 2004 Nov; 114(5):e541-7. PubMed ID: 15520087
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Functional performance in young Australian children with achondroplasia.
    Ireland PJ; McGill J; Zankl A; Ware RS; Pacey V; Ault J; Savarirayan R; Sillence D; Thompson EM; Townshend S; Johnston LM
    Dev Med Child Neurol; 2011 Oct; 53(10):944-50. PubMed ID: 21838822
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development of the Weight-Related Sign and Symptom Measure.
    Brod M; Højbjerre L; Pfeiffer KM; Sayner R; Meincke HH; Patrick DL
    J Patient Rep Outcomes; 2017; 2(1):17. PubMed ID: 29757304
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Quality of life in children, adolescents, and young adults with achondroplasia].
    Rohenkohl AC; Bullinger M; Quitmann J
    Orthopade; 2015 Mar; 44(3):212-8. PubMed ID: 25217045
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development and validation of the Diabetic Peripheral Neuropathic Pain Impact (DPNPI) measure, a patient-reported outcome measure.
    Brod M; Blum SI; Bushnell DM; Ramasamy A
    Qual Life Res; 2015 Dec; 24(12):3001-14. PubMed ID: 26068732
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development and exploration of the content validity of a patient-reported outcome measure to evaluate the impact of migraine- the migraine physical function impact diary (MPFID).
    Hareendran A; Mannix S; Skalicky A; Bayliss M; Blumenfeld A; Buse DC; Desai PR; Ortmeier BG; Sapra S
    Health Qual Life Outcomes; 2017 Nov; 15(1):224. PubMed ID: 29149901
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.